Insamed upgraded by CE Unterberg

Insamed Inc. was upgraded Thursday by CE Unterberg Towbin to buy from market perform. Glen Allen, Va.- based Insamed engages in the development and commercialization of drug products for the treatment of metabolic diseases and endocrine disorders. Insamed shares rose Thursday by 5 cents, or 5.56% to close at 95 cents on volume of 2 million shares versus a three-month running average of 431,005.

Dade Behring cut by CE Unterberg

Dade Behring Holdings Inc. was downgraded Thursday by RBC Capital Markets to sector perform from outperform. Deerfield, Ill.-based Dade Behring makes diagnostics instruments and provides services to clinical laboratories. Dade Behring shares dropped Thursday by $1.54, or 2.3% to close at $65.47 on volume of 609,385 shares versus a three-month running average of 254,408.

Ventana downgraded by Bear Stearns

Ventana Medical Systems Inc. was downgraded Thursday by Bear Stearns & Co. Inc. to peer perform from outperform. Tucson-based Ventana makes instruments and reagents that automate slide staining in anatomical pathology and drug discovery laboratories. Ventana shares lost Thursday by $1.13, or 2.56% to close at $42.94 on volume of 801,408 shares versus a three-month running average of 339,957.

Biomet initiated by Deutsche at hold

Biomet Inc. coverage was initiated Thursday by Deutsche Bank Securities at a hold rating. Warsaw, Ind.-based Biomet makes products used primarily by musculoskeletal medical specialists in surgical and nonsurgical therapy, and reconstructive surgery. Biomet shares slipped Thursday by 24 cents, or 0.64% to close at $37.18 on volume of 1.56 million shares versus a three-month running average of 2.1 million.

Invacare initiated by Legg Mason

Invacare Corp. coverage was initiated Thursday by Legg Mason at a hold rating. Elyria, Ohio-based Invacare makes medical equipment such as wheelchairs and nebulizers. Invacare shares were up Thursday by 6 cents, or 0.13% to close at $45.50 on volume of 81,100 shares versus a three-month running average of 107,945.

NexMed initiated by Rodman & Renshaw

NexMed Inc. coverage was initiated Thursday by Rodman & Renshaw at a market perform rating. Robbinsville, N.J.-based NexMed focuses primarily on patented pharmaceutical products based on a penetration enhancement through the skin. NexMed shares gained Thursday by 3 cents, or 2.34% to close at $1.31 on volume of 164,529 shares versus a three-month running average of 94,892.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.